Loading...

VF May Webinar: Vasculitis--A 30 Year Perspective

1,405 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on May 15, 2016

Introduction of Dr. Carol Langford 0:11
Summary of Presentation by Dr. Langford 2:29
Vasculitis: An Historical Perspective 4:21
First description of Vasculitis (150 years ago) 4:42
When the various diseases were discovered 5:11
Introduction of Prednisone 6:29
Two pioneers in early treatment of vasculitis 8:33
Discovery of ANCA and its link to vasculitis 9:39
Dr. Hoffman and early work at the NIH 12:36
Classification and Nomenclature of vasculitis 15:03
Giant Cell Arteritis—Early work of Dr. Matteson 16:42
Single organ vasculitis 17:42
One of first studies of GPA Wegener’s 18:24
Early 2000’s: Development of Biologic Agents 21:24
Creation of Vasculitis Clinical Research Consortium 23:35
First study of Rituximab by Dr. Specks (2001) 24:23
FDA Approves Rituximab for Vasculitis (2011) 25:40
Abatacept Study (2013) 26:20
Renaming of some vasculitis diseases (2012) 26:44
Where we are today: Genetics and Vasculitis 27:13
Clinical trials of new medications 28:33
V-PPRN 29:08
Where are we going in vasculitis research 31:30
Funding Challenges 32:24
2016 Gary L. Hoffman VF Fellowship 33:08
The role of the VF over the last 30 years 34:47

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...